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Aim To evaluate the effect of hyperbaric oxygen therapy 
(HBOT) on superoxide dismutase 2 (SOD2) expression pat-
tern after the cortical stab injury (CSI).
Methods CSI was performed on 88 male Wistar rats, di-
vided into control, sham, lesioned, and HBO groups. HBOT 
protocol was the following: pressure applied was 2.5 abso-
lute atmospheres, for 60 minutes, once a day for consecu-
tive 3 or 10 days. The pattern of SOD2 expression and cel-
lular localization was analyzed using real-time polymerase 
chain reaction, Western blot, and double-label fluores-
cence immunohistochemistry. Neurons undergoing de-
generation were visualized with Fluoro-Jade®B.
Results CSI induced significant transient increase in SOD2 
protein levels at day 3 post injury, which was followed by 
a reduction toward control levels at post-injury day 10. At 
the same time points, mRNA levels for SOD2 in the injured 
cortex were down-regulated. Exposure to HBO for 3 days 
considerably down-regulated SOD2 protein levels in the 
injured cortex, while after 10 days of HBOT an up-regula-
tion of SOD2 was observed. HBOT significantly increased 
mRNA levels for SOD2 at both time points compared to 
the corresponding L group, but they were still lower than 
in controls. Double immunofluorescence staining revealed 
that 3 days after CSI, up-regulation of SOD2 was mostly 
due to an increased expression in reactive astrocytes sur-
rounding the lesion site. HBOT attenuated SOD2 expres-
sion both in neuronal and astroglial cells. Fluoro-Jade®B 
labeling showed that HBOT significantly decreased the 
number of degenerating neurons in the injured cortex.
Conclusion HBOT alters SOD2 protein and mRNA levels 
after brain injury in a time-dependent manner.
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Traumatic brain injury (TBI) is among the most disabling 
injuries and represents the major health problem world-
wide (1). TBI involves primary and secondary injury. Pri-
mary injury is the result of immediate mechanical dam-
age of neural pathways that occurs at the time of injury 
and triggers a cascade of events known as secondary in-
jury, which causes further damage to the brain. Second-
ary injury evolves over time and may persist for months 
to years after TBI causing primarily unaffected neurons 
to degenerate. Therefore, it should be considered as a 
chronic disease process and main target for potential 
therapies (2,3).
As a part of secondary post-injury cascade, oxidative stress, 
among the other events, is a prominent one (1). It has been 
demonstrated that reactive oxygen species (ROS), if exceed 
the capacity of the anti-oxidative defense, lead to oxidative 
stress and cellular damage after brain trauma (4-6). Addi-
tionally, it has been shown that depletion of antioxidant 
systems following trauma could adversely affect synaptic 
function and plasticity (7).
The first line of defense against ROS is in the place where 
it all begins – mitochondria. Manganese superoxide dis-
mutase (SOD2), located in the mitochondrial inner mem-
brane and matrix, is a critical antioxidant enzyme that cata-
lyzes the dismutation of superoxide radical to oxygen and 
hydrogen peroxide. In different brain pathologies, the in-
duction of SOD2 varies and depends on the type of injury 
(8), and most data point out the neuroprotective role of 
SOD2 in brain injury (9,10). In addition, experiments with 
SOD2 deficient mice who suffered from early degenera-
tion have shown how essential this enzyme was for nor-
mal brain functioning (11,12). It has also been found that 
SOD2 expression was directly correlated with the grade of 
brain tumors in humans (13).
Despite the amount of work that has been done in order to 
better understand TBI, an adequate therapy is still lacking. 
In the past decade, hyperbaric oxygen therapy (HBOT) be-
came one of the more frequently used medical tools and it 
appears to be a good therapeutic solution for a variety of 
conditions (14). Beneficial effects of HBOT as adjuvant ther-
apy with surgery were also observed in the treatment of 
complex war injuries. Irrespectively of the type of surgical 
strategy applied, HBOT significantly reduced the frequency 
of wound complications and the time to wound stabiliza-
tion (15). HBOT is a therapeutic approach where the pa-
tient is exposed to 100% oxygen at pressures higher than 
ambient (1 atmosphere absolute [1 ATA]). This leads to an 
increased blood oxygen level, which than can penetrate to 
ischemic areas more deeply than under normobaric condi-
tions (16-18). In our recently published article (19), we have 
shown that HBOT can recover locomotor performances in 
rats after the brain injury. Although there is a large body ev-
idence that HBOT is useful as a therapy for brain injury (18-
23), there is also data indicating that the use of hyperbaric 
oxygen can have serious side effects (14,24-26). The main 
concern in HBOT is oxidative stress and/or oxygen toxic-
ity that can affect multiple organs. However, these unwel-
come side-effects have often been dependent on treat-
ment parameters – pressure and duration of the treatment 
(25,27,28). The data on the exact mechanisms by which 
HBOT exerts its positive effects are deficient. Thus, in the 
present study we investigated the effect of HBOT on tem-
poral expression pattern and cellular distribution of SOD2 
after cortical stub injury (CSI).
MeThoDS
Animals
The study used 88 ten weeks old male Wistar rats, weigh-
ing 250 ± 30 g at the time of surgery. Animals were housed 
4 per cage and maintained at the animal facility of the In-
stitute for Biological Research “Siniša Stanković” (Belgrade, 
Serbia) in accordance with institutional guidelines, under 
standard conditions (23 ± 2°C, 12h/12h light/dark cycle, 
food and water ad libitum). After the acclimatization pe-
riod of one week, animals were randomly organized into 
the following groups (n = 8 per group): control group (C) 
– intact rats; control HBO group (CHBO) – intact rats sub-
jected to the HBO protocol for 3 and 10 consecutive days; 
sham group (S) – animals that underwent surgical proce-
dure without skull opening, sacrificed 3 or 10 days post 
injury (dpi); sham HBO group (SHBO) – the animals that 
underwent sham surgery and were subjected to the HBO 
protocol for 3 or 10 consecutive days; lesion group (L) – 
the animals that passed CSI and were sacrificed 3 or 10 
dpi; and lesion HBO group (LHBO) – CSI rats subjected 
to the HBO protocol for 3 or 10 consecutive days. Experi-
mental protocol received prior approval from the Ethical 
Committee of the School of Medicine, University of Bel-
grade (No. 3027/2), and was conducted in strict accor-
dance with recommendations given in NIH Guide for the 
Care and Use of Laboratory Animals (NIH publication No. 
85-23, http://grants.nih.gov/grants/olaw/Guide-for-the-
Care-and-Use-of-Laboratory-Animals.pdf ). All efforts 
were made to minimize the number of used animals 
and their suffering.
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Surgical procedure
A previously described model of cortical stab injury (CSI) 
was used (29). Before starting the surgical procedure, rats 
were anesthetized with ether. After the onset of anesthetic, 
rats were shaved and placed in the stereotaxic frame. Us-
ing a sterile scalpel blade the head was incised along the 
midline of the scalp to expose the bregma, and the bleed-
ing was minimized with cotton swabs. Handheld 1-mm-
wide dental drill was inserted vertically in the cranium on 
the left side. The coordinates of stab lesion to the left cor-
tex were as follows: 2 mm posterior to the bregma, 2 mm 
lateral from the midline, and to a depth of 2 mm into the 
brain (30). The incision was closed with sutures. Rats from 
the sham control groups were anesthetized, placed in the 
stereotaxic frame, and subjected to the same surgical pro-
cedure, without causing further damage to the skull. Ani-
mals were placed in a heated room and monitored while 
recovering from anesthesia. Intact, age-matched animals 
were processed as controls. After the surgery, the rats were 
kept at warm and left up to 2 hours to recover before start-
ing HBOT protocol.
hBoT protocol
The rats were placed into experimental HBO chambers 
and exposed to 100% oxygen according to the following 
protocol: 10 minutes compression, 2.5 atmospheres abso-
lute (ATA) for 60 minutes, and 10 minutes decompression. 
HBOT was performed once a day, for 3 or 10 consecutive 
days. This protocol corresponds to a standard hyperbaric 
oxygen treatment that is routinely used in the clinical set-
ting of Center for Hyperbaric Medicine, Belgrade, Serbia 
(26), and is in line with the recommendations of The Com-
mittee of the Undersea and Hyperbaric Medical Society 
that a treatment pressure only from 2.4 to 3.0 ATA should 
be used as appropriate (31). Each exposure was started at 
the same hour to exclude any confounding issues associ-
ated with the changes in biological rhythm. Body tempera-
ture was not changed significantly after the HBOT.
Tissue preparation
Five rats were taken from each group for immunoblot and 
gene expression analyses. After the end of treatment pro-
tocol (at 3 or 10 dpi) animals were sacrificed by decapi-
tation under deep ether anesthesia. Immediately after 
decapitation, the brains were quickly removed from the 
skull. From injured (left) cortices 2 mm sections around 
the center of lesion were dissected on ice and frozen 
in liquid nitrogen. The same piece of tissue was dissected 
from the left cortices of sham and intact controls. Tissue 
was stored at -80°C until processed using TRIzol isolation 
method (Invitrogen, Grand Island, NY, USA), according to 
the manufacturer’s instructions. A slight modification was 
made regarding protein resuspension part of the protocol. 
Due to poor solubility of the protein pellet, it was grinded 
in liquid nitrogen and then resuspended in 1% SDS. The 
resulting supernatant was centrifuged at 10 000 g for 10 
minutes and the supernatant was collected. Protein con-
tent was determined by the method of Markwell et al (32), 
and samples were kept at -20°C until use.
RNA isolation and gene expression analyzes
After total RNA isolation and treatment with DNase (Fer-
mentas, St. Leon-Rot, Germany), it was reverse transcribed 
to cDNA using the High-Capacity cDNA Reverse Transcrip-
tion Kit (Applied Biosystems, Carlsbad, CA, USA). Quantita-
tive real-time PCR (RTQ-PCR) was conducted using SYBR 
Green technology (Applied Biosystems, Carlsbad, CA, USA) 
and analyzed on AbiPrism 7000 (Applied Biosystems). The 
list of all primers (Invitrogen) designed in the free-access 
internet program Primer 3 is given in Table 1.
Western blot analysis
Immunoblot analysis was performed by standard protocol. 
Briefly, equal amounts of cortical tissue preparation (10µg/
lane) were resolved by 7.5% SDS-PAGE gel according to 
Laemmli (33) and transferred to a polyvinylidene fluoride 
(PVDF) support membrane. Membranes were blocked in 
5% bovine serum albumin (BSA) and incubated with rab-
bit polyclonal anti-SOD2 antibody (1:1000; Abcam, Cam-
bridge, UK) overnight at 4°C. After incubation with donkey 
anti-rabbit IgG horseradish peroxidase conjugated sec-
ondary antibody (1:5000 dilution; Santa Cruz Biotechnol-
ogy, Santa Cruz, CA, USA), a visualization was performed 
on x-ray films (Kodak) with the use of chemiluminescence. 
For each SOD2 blot, β-tubulin (Invitrogen) was used as a 
loading control. Optical densities of SOD2 immunoreac-
tive bands were calculated as arbitrary units in the Image 
TABLe 1. List of primers used for real-time polymerase chain 
reaction.
Primer Sequence 5’→3’ Length (bp)
β-Actin f   agattactgccctggctcct
r   acatctgctggaaggtggac
119
SOD2 f   cagatcatgcagctgcacca
r   tcagtgcaggctgaagagca
133
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Quant program after local background subtraction. The re-
sults are expressed as the ratio of SOD2 and β-tubulin opti-
cal densities relative to the value obtained for intact con-
trol. Data presented in graphs are mean values ± standard 
error of the mean obtained from six immunoblots.
Immunohistochemistry
After overnight fixation in 4% paraformaldehyde in 0.1 M 
phosphate buffer, pH 7.4, brains (3 per group) were cryo-
protected in graded sucrose (10%-30% in 0.2 M phosphate 
buffer, pH 7.4) at 4°C. Brains were frozen in 2-methyl bu-
tane and stored at -80°C until cryosectioning. Immunohis-
tochemistry was performed on 25 µm-thick coronal sec-
tions. Heated citrate buffer (pH 6) and 0.3% triton-X were 
used as antigen retrieval and membrane permeabilization 
steps, respectively. Blocking was done using 1% BSA. Co-
localization of SOD2 with marker of neuronal cell bodies, 
NeuN, was examined with double immunofluorescence 
labeling using rabbit polyclonal anti-SOD2 (1:500, rabbit 
IgG, Abcam, Cambridge, MA, USA) and mouse monoclonal 
anti-NeuN antibody (1:500, Millipore, Vienna, Austria). Colo-
calization of SOD2 with marker of astrocytes was examined 
with double immunofluorescence labeling using rabbit 
polyclonal anti-SOD2 and mouse monoclonal anti-GFAP 
antibody (1:400, Abcam). Visualization of reaction was ob-
tained using appropriate secondary fluorescent antibod-
ies (1:250, Alexa Fluor 555 goat anti-mouse IgG and Alexa 
Fluor 488 donkey anti-rabbit, Invitrogen), and nuclei were 
marked using DAPI (Invitrogen). The sections were mount-
ed in Mowiol (Calbiochem, San Diego, CA, USA). To test the 
specificity of the reaction, brain sections were treated in 
the same way with the omission of the primary antibodies. 
The sections were examined and photographed with Carl 
Zeiss Axiovert microscope (Zeiss, Gottingen, Germany).
Total fluorescence measurements were performed with 
Image J, as described in Burgess et al (34). Total fluores-
cence intensity of SOD2 positive cells, labeled with NeuN 
or GFAP (respectively) was measured in 4 fields under the 
area of the screen (0.38 mm2) in 4 sections per animal 
(n = 3) in the region around the injury (or corresponding 
region in non-injured animals).
Fluoro-Jade B staining and image analysis
Fluoro-Jade B staining was performed in order to visualize 
neuronal cells undergoing degeneration and cell death. 
Brains and sections were prepared as for immunohis-
tochemistry procedure. The slides were first immersed in a 
basic alcohol solution consisting of 1% NaOH in 80% etha-
nol and distilled water, and incubated in 0.06% KMnO4 so-
lution for 10 minutes. The slides were transferred for 10 min-
utes to a 0.0001% solution of Fluoro-Jade®B (FJB, Chemicon 
International, Temecula, CA, USA) dissolved in 0.1% acetic 
acid and then rinsed by three changes of distilled water 
for 1 minute per change. The nuclei were marked using 
DAPI, and the slides were coverslipped with Mowiol (Cal-
biochem). The sections were examined with Carl Zeiss Ax-
iovert microscope (Zeiss). Cells labeled with Fluoro-Jade B 
were observed as individual green spots. The number of 
degenerating neurons labeled by FJB staining was count-
ed in 3 fields under the area of the screen (0.38 mm2) in 4 
sections per animal (n = 3) in the region around the injury 
(or corresponding region in non-injured animals). 
Statistical analysis
All data are presented as mean ± standard error of the 
mean. Statistical significance of differences between the 
groups was determined using the one-way analysis of 
variance (ANOVA for repeated measures), with the treat-
ment protocol and time post-surgery as factors. P value 
less than 0.05 (P < 0.05) or 0.001 (P < 0.001) was considered 
as significant.
ReSuLTS
Western blot analysis showed that the antibody used for 
SOD2 detection recognized one band at approximately 
26 kDa (Figure 1A). Quantification of total levels of SOD2 
protein in all examined groups (Figure 1B) revealed that, 
compared to control (0.997 ± 0.007), sham operation insig-
nificantly altered SOD2 protein levels at both time points 
(3 and 10 dpi), while after CSI significant transient increase 
was observed. Thus, a significant 2.5 fold up-regulation 
of SOD2 protein levels detected at 3 dpi (2.373 ± 0.368), 
(P < 0.001, Figure 1B) was followed by a reduction toward 
control levels 10 dpi (0.953 ± 0.137). The exposure to HBO 
for 3 and 10 days caused a significant (Figure 1B) up-reg-
ulation of SOD2 in control and sham-operated groups. 
The exception was SHBO group, which was treated with 
HBO for 10 days and in which this increase was not signifi-
cant. Interestingly, 3 days of HBO treatment considerably 
down-regulated SOD2 protein levels in the injured cor-
tex (1.330 ± 0.088), when compared to untreated L group 
(2.373 ± 0.279), (P < 0.05), while after 10 days of HBOT there 
was a significant (39%, P < 0.05) up-regulation of SOD2 
(1.327 ± 0.121), when compared to untreated L group 
(0.953 ± 0.137).
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Surprisingly, RTQ-PCR analysis revealed that CSI signifi-
cantly reduced SOD2 mRNA levels at 3 dpi (42.62 ± 1.74) 
(for 57%) and 10 dpi (57.06 ± 10.70), (for 43%) (P < 0.001 
and P < 0.05 respectively, Figure 2) when compared to 
control (100 ± 12.09), while sham operation had no influ-
ence on SOD2 expression. However, although we noticed 
that HBOT significantly (P < 0.05) increased mRNA levels for 
SOD2 at both time points (2.1-fold at 3 dpi [90.11 ± 13.44] 
and 32% at 10 dpi [57.06 ± 10.70]) compared to the cor-
responding L group, they were still lower in comparison 
to control. Furthermore, it should be noted that the ex-
posure to HBOT for 3 and 10 days increased mRNA lev-
els for SOD2 in control (134.05 ± 7.59 after 3 days of HBOT 
and 125.99 ± 4.38 after 10 days of HBOT) and sham groups 
(151.84 ± 3.24 after 3 days of HBOT and 129.22 ± 23.56 after 
10 days of HBOT), (P < 0.05, Figure 2).
Double immunofluorescence staining was performed to 
detect the effect of CSI and HBOT on cellular localization of 
SOD2. Neuronal characterization of SOD2 was performed 
using NeuN as a marker of neurons and DAPI for the label-
ing of the cell nuclei (Figure 3a). In the control sections, 
weak SOD2 immunoreactivity was mainly located in the 
neuronal soma (Figure 3a, A-C). Three days after the inju-
ry, intense staining was observed in a number of neurons 
in the vicinity of the lesion site (Figure 3a, D-F). Repetitive 
HBOT reduced SOD2 staining in the lesioned cortex when 
compared to injury alone (Figure 3a, I-L). Ten days after the 
injury, the lesioned cortex of both L (Figure 3a, J-L) and 
LHBO (Figure 3a, M-O) groups showed down-regulation 
of SOD2 immunoreactivity, and only a paucity of SOD2+/
NeuN+ neurons was seen. Quantitative analysis of fluo-
rescence signal in neurons used to determine changes in 
SOD2 expression pattern (Figure 3b) revealed that at 3 dpi 
SOD2 fluorescence signal increased in NeuN+ cells about 
3-fold around the lesion site (2.83 ± 0.76, P < 0.001), while 
exposure to HBO returned signal intensity to almost con-
trol levels (1.29 ± 0.18) (Figure 3b). Ten days after the CSI, 
the fluorescent signal in neurons in the perilesioned cortex 
was significantly decreased (0.75 ± 0.24) compared to 3 dpi 
and HBOT did not change this.
Interestingly, the decrease in neuronal SOD2 was accompa-
nied by a significant up-regulation in astroglial cells, which 
was confirmed with double immunofluorescence staining 
FIguRe 1. The effect of cortical stab injury (CSI) and hyperbaric 
oxygen therapy (hBoT) on superoxide dismutase 2 (SoD2) 
protein expression. The expression of SoD2 protein was as-
sessed by Western blot analysis. Detection of β-tubulin was 
also carried out to confirm the equal loading of proteins. C – 
intact rats, ChBo – intact rats subjected to hBoT for 3 and 10 
days, S – animals that underwent sham surgery, sacrificed at 3 
or 10 dpi, ShBo – sham animals subjected to hBoT for 3 or 10 
days, L – the animals that passed CSI sacrificed at 3 or 10 dpi, 
and LhBo – CSI rats subjected to hBoT for 3 or 10 days. (A) 
Representative immunoblots for SoD2 and β-tubulin. (B) Rela-
tive optical densities for SoD2 immunoreactive bands from six 
independent experiments were calculated as arbitrary units in 
the Image Quant program, and presented relative to control 
as mean ± standard error of the mean. The values of *P < 0.05 
or **P < 0.001 were considered significant, this significance is 
shown as a dot (referent group) compared to a diamond (the 
group that is being compared).
FIguRe 2.The effect of SCI and hBoT on SoD2 mRNA expres-
sion. expression of SoD2 mRNA was measured by real time 
polymerase chain reaction (RTQ-PCR). The levels of each mRNA 
were normalized to those of the house-keeping gene β-actin. 
SoD2 mRNA relative expression values were compared to the 
control group and presented as mean ± standard error of the 
mean. The values of *P < 0.05 or **P < 0.001 were considered 
significant, this significance is shown as a dot (referent group) 
compared to a diamond (the group that is being compared). 
Acronyms are explained in the legend to Figure 1.
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for SOD2 and GFAP as a marker of astrocytes, while DAPI 
was used for the labeling of the cell nuclei (Figure 4a). In 
control sections, (Figure 4a, A-C) scattered, weak SOD2 im-
munoreactivity was seen in astrocytes. Three days post-in-
jury, SOD2 staining in reactive astrocytes surrounding the 
site of injury was obviously increased (Figure 4a, D-F). Con-
versely, in LHBO group SOD2 immunoreactivity in GFAP-
expressing astrocytes was lower (Figure 4a, G-I). At 10 days 
after CSI, a huge number of GFAP-expressing hypertrophic 
astrocytes expressing SOD2 was seen in the close vicinity 
to the lesion site (Figure 4a, J-L), while after 10 successive 
HBOTs their number was reduced (Figure 4a, M-O). Quan-
titative analysis of astrocytes co-expressing SOD2 showed 
that, compared to control (1 ± 0.25), at 3 dpi intensity of 
SOD2 fluorescence increased 6.5-fold (6.54 ± 0.40), while 
fluorescence signal was reduced by a factor of 2 in the 
LHBO group (3.15 ± 0.33) (P < 0.001) (Figure 4b). This rela-
tionship between SOD2 fluorescence signal in L and LHBO 
was maintained at 10 dpi (8.6-fold (8.59 ± 0.25) vs 4.9-fold 
[4.90 ± 0.36], respectively).
FJB staining was performed to evaluate the effect of CSI 
and HBOT on neuronal degeneration (Figure 5a). After CSI, 
the number of FJB-positive cells in the injured cortex in-
creased at 3 dpi (7.11 ± 0.35) (Figure 5a, D-F) and 10 dpi 
(5.29 ± 0.14) (Figure 5a, J-L) 7- and 5.3-fold, respectively 
(Figure 5b). The exposure to HBO for 3 (Figure 5a, G-I) and 
10 days (Figure 5a, M-O) reduced the number of FJB-posi-
tive cells about 2.5-fold (3.05 ± 0.37 and 2.05 ± 0.30, respec-
tively) in the injured cortex (Figure 5b). In addition, no sig-
nificant difference in the number of degenerating neurons 
was observed between the sections from C, CHBO, S, and 
SHBO groups (data not shown).
DISCuSSIoN
It is well known that ROS generated from the mitochondria 
have been implicated in different models of brain injury 
and that they may lead to apoptosis as a part of the sec-
ondary injury (12,35-37). Since SOD2 can be induced by 
various insults in the CNS, and is the first line of defense 
FIguRe 3. (a) The effect of CSI and hBoT on neuronal localization of SoD2. Double immunofluorescence staining with SoD2 (green) 
and NeuN (red) was used to detect neuronal localization of SoD2. Nuclei were stained with DAPI (blue). (A, B, C) In control, non-
injured cortex expression of SoD2 was mainly seen in neurons (arrow). (D, E, F) CSI increased intensity of SoD2 staining in neurons 
at 3 dpi (arrows). (G, H, I) SoD2 staining was decreased to almost control levels after 3 days of repetitive hBoT. (J, K, L) Ten days 
after the CSI, SoD2 staining observed in neurons was similar to those seen in control sections. (M, N, O) SoD2 staining remained 
unchanged after 10 days of repetitive hBoT in comparison to 10dpi group. Scale bar applies to all images: 20 μm. Figure 3 (b) Quan-
tification of fluorescence signal of SoD2 (green) in NeuN positive cells. Relative fluorescence intensity for SoD2 protein in neurons 
shows significant increase in SoD2 signal in neurons at 3 dpi, while after hBoT signal decreases to almost control levels at the same 
time point. Ten days after the CSI and after hBoT of the same group, total fluorescence intensity for SoD2 was unchanged compared 
to the control. All values were compared to the control group and presented as mean ± standard error of the mean. The values of 
*P < 0.05or **P < 0.001 were considered significant, this significance is shown as a dot (referent group) compared to a diamond (the 
group that is being compared). Acronyms are explained in the legend to Figure 1.
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against ROS, in this study we investigated the impact of 
CSI and HBOT on temporal pattern of its protein and 
gene expression. We found that CSI significantly altered 
SOD2 expression in a time-dependent manner, which is in 
agreement with a large body of evidence that is showing 
changes in enzyme expression and function after brain in-
sult (8,38-40).
We showed that in control brain sections, the majority 
of SOD2 immunofluorescence was observed in neurons, 
which is to be expected if we consider neurons as the 
brain cells with the highest oxygen consumption, con-
stantly submitted to oxidative stress (41). It is important to 
note that after CSI remarkable, transient increase in SOD2 
on the protein level was detected at 3 dpi. At the cellular 
level, we demonstrated that enhanced SOD2 staining seen 
in neurons was even more pronounced in reactive astro-
cytes bordering the lesion site, indicating that observed 
SOD2 induction was mostly due to up-regulation in astro-
cytes. Enhanced staining for SOD2 in neurons and astro-
cytes 48 hours after cortical injury in rats was previously 
reported by Bidmon et al (8), who suggested that early in-
crease in SOD2 protects the cells in injured regions from 
superoxide-induced damage. Accordingly, increased pro-
tein levels of SOD2 that we detected at 3 dpi are most likely 
the response to elevated ROS after the injury. Ten days af-
ter the CSI, SOD2 protein levels and fluorescence intensity 
in neurons returned to the control levels, which is also in 
agreement with the study by Bidmon et al (8). Similarly, in 
the model of excitotoxically induced neurodegeneration, 
FIguRe 4. (a) The effect of CSI and hBoT on astrocytic localization of SoD2. Double immunofluorescence staining with SoD2 
(green) and gFAP (red) was used to detect localization of SoD2 in astrocytes. Nuclei were stained with DAPI (blue). (A, B, C) In 
control, non-injured cortex low expression of SoD2 was seen in astrocytes (arrow). (D, E, F) CSI increased intensity of SoD2 stain-
ing in astrocytes at 3 dpi (arrows). (G, H, I) After exposure to hBoT, SoD2 staining in astrocytes was decreased compared to 3 dpi. 
(J, K, L) Ten days after CSI, significant increase in SoD2 was observed in reactive astrocytes. (M, N, O) SoD2 staining in astrocytes 
was decreased after 10 days of repetitive hBoT compared to 10 dpi. Scale bar applies to all images: 20μm. Figure 4 (b) Quantifica-
tion of fluorescence signal of SoD2 (green) in gFAP positive cells. Relative fluorescence intensity for SoD2 protein in astrocytes 
shows significant increase in SoD2 signal in astrocytes at 3 dpi, while after hBoT signal decreases by a factor of 2. Ten days after 
CSI about 4 times greater fluorescence signal was observed in glial fibrilary acidic protein (gFAP) positive cells compared to 
control. After 10 dpi with hBoT, SoD2 fluorescence signal was reduced by a factor of 2 as well. All values were compared to the 
control group and presented as mean ± standard error of the mean. The values of *P < 0.05 or **P < 0.001 were considered signifi-
cant, this significance is shown as a dot (referent group) compared to a diamond (the group that is being compared). Acronyms 
are explained in the legend to Figure 1.
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2-fold increase in SOD2 protein observed at 24 hours af-
ter injection of quinolinic acid declined slowly over the fol-
lowing 10 days (42). Further, our result is consistent with 
earlier findings that prolonged hypoxia/ischemia that oc-
curs in injured tissue results in a general decrease in SOD2 
levels in neurons, and is discussed as an additional factor 
in causing neuronal degeneration (43). However, the de-
crease in neuronal SOD2 that we have noticed at 10 dpi 
was accompanied by significant up-regulation in highly re-
active astroglial cells. A comparable extensive induction in 
reactive astrocytes and in the astroglial scar was showed 
for Cu/Zn SOD at 3, 5, and 7 days following excitotoxic inju-
ry in the postnatal rat brain (44). Consequently, astrocytes 
seem to be the main cell type that increases the total an-
tioxidant capabilities in the nervous tissue after a lesion. 
The fact that they are more capable of handling oxidative 
stress conditions can explain their elevated resistance to 
cell death after an injury (44). In this regard, previous stud-
ies showed that Cu/Zn SOD-overexpressing astrocytes had 
increased resistance to oxidative damage (45). Having in 
mind that glial cells have an important role in supporting 
neighboring neurons, the appearance of injury-induced 
up-regulation of SOD2 in astrocytes seen at 3 and 10 dpi, 
therefore, seems to be a critical determinant for neuronal 
survival. Our results are in accordance with the study by Xu 
et al (46), who suggested that SOD2 overexpression in hip-
pocampal astrocytes would improve the survival of CA1 
neurons after transient forebrain ischemia.
Unexpectedly, our data point to discrepancies in SOD2 
mRNA and protein levels. Namely, 3 days after the injury a 
significant increase in SOD2 observed at protein level was 
associated with decreased SOD2 mRNA levels when com-
pared to control. To our knowledge, we are the first to re-
port a difference in SOD2 expression at protein vs mRNA 
level after TBI. A difference between SOD2 expression at 
protein and mRNA level was previously seen in cerebral 
endothelial cells 6 hours following sublethal oxidative 
stress (47). Many studies were performed in order to com-
pare mRNA and protein expression on a large scale, and it 
was indicated that mRNA levels only partly correlated with 
the corresponding protein concentrations (48-50). The rea-
son for this divergence could be post-transcriptional regu-
lation processes involving mRNA stability, translation initia-
FIguRe 5. (a) Fluoro-Jade®B (FJB) staining of rat brains three and ten days after CSI and hBoT. Double immunofluorescence staining 
with FJB (green) and DAPI (blue) was used to detect degenerating neurons. (A, B, C) only a few neurons were FJB-positive in C group. 
(D, E, F) An increase in the number of FJB-positive cells was apparent 3 dpi. (G, H, I) Decrease in number of degenerated neurons 
after hBoT. (J, K, L) The number of FJB-positive cells is increased at 10 dpi. (M, N, O) After 10 hBoT, a decrease in number of degener-
ated neurons was seen. Degenerating neurons are marked with arrows. Scale bar applies to all images: 20 μm. Figure 5 (b) Quanti-
tive analysis of Fluoro-Jade®B (FJB) staining of rat brains three and ten days after CSI and hBoT. All values were compared to the C 
group and presented as mean ± standard error of the mean. The values of *P < 0.05 or **P < 0.001 were considered significant, this 
significance is shown as a dot (referent group) compared to a diamond (the group that is being compared). Acronyms are explained 
in the legend to Figure 1.
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tion, and protein stability. This dissimilarity between SOD2 
mRNA and protein expression emphasize the importance 
of investigation of posttranscriptional regulatory mecha-
nisms that can be unveiled only through integrated analy-
ses of both proteins and mRNAs.
Oxygen is one of the frequently used therapeutic agents. 
Inattentive use of oxygen at high partial pressures (pO2) 
can cause damage due to excessive production and ac-
cumulation of ROS (51). The degree of toxicity is shown to 
be dependent on treatment parameters: pressure and du-
ration of the treatment (14,18,25,27,52). This led to skepti-
cism regarding the use of HBOT (53), but also to numerous 
research studies trying to determine the optimal param-
eters for HBOT in regard to both pressure of oxygen and 
duration of treatment. The clinically approved maximum 
pressure and duration of HBO exposure are 3 ATA and 120 
minutes, respectively (31), although the most commonly 
used protocol for standard therapeutic purposes is slight-
ly lower (1.8-2.8 ATA for 60-90 minutes) (53). In agreement 
with this knowledge, and according to our previous ex-
perience (19), we exposed rats to HBO. Using such HBOT 
protocol we avoided the potential risk of oxygen toxicity 
and prevented the appearance of convulsions (54,55). We 
started the HBOT protocol up to 2 hours after the surgery, 
having in mind the observations of other authors that effi-
cacy of HBOT was considerably attenuated by 12 hours af-
ter TBI (18). The correctness of applied HBOT protocol and 
detection of possible histopathological changes after CSI 
and HBOT were evaluated using FJB staining, which is a rel-
atively simple method for reliable detecting of dying neu-
rons, regardless of the cell death cause (56), and compara-
ble with results obtained using TUNEL staining, as another 
marker for neuronal death (57). Regarding HBOT effect on 
uninjured control groups, no significant difference in the 
number of FJB-positive cells was observed. Importantly, ex-
posure to HBOT for 3 and 10 days significantly decreased 
the number of dying neurons, indicating that HBOT did not 
contribute to neuronal death after the brain injury. Neuro-
protective effect of HBOT in brain injury has been demon-
strated by several authors and may be mediated by preser-
vation of mitochondrial membrane properties (58)
Our data showed that HBOT, when applied on non-injured 
animals, increased SOD2 expression both on protein and 
mRNA level, probably due to hyperoxic challenge. Indeed, 
SOD2 is known as an inducible enzyme that may be ac-
tivated in a variety of stressful conditions, including the 
changes in oxygen level (59). Furthermore, our results are 
in agreement with reports that HBOT increases SOD 
activity in several tissues (60). However, HBO is therapeu-
tic modality with dual effects: it produces oxidative stress 
by itself but reduces oxidative stress when used in patho-
logic conditions (61). Similarly, we found that the exposure 
to HBOT for 3 and 10 days after the cortical injury reduced 
oxidative stress by returning SOD2 expression toward levels 
close to physiological. These results are consistent with our 
recent findings that activity of SOD, which was reduced af-
ter ablation of sensorimotor cortex, after exposure to HBO 
is elevated up to the values obtained in the control group 
(unpublished data). Protective effects of HBOT related to in-
creased production of SOD2 have been demonstrated in 
the model of ischemia. It has been shown that HBO precon-
ditioning improved the tolerance to ischemia (62). More-
over, when administered during ischemia, HBOT reduced 
formation of hydroxyl radicals (63). It was proposed that the 
underlying mechanism could be reduced glutamate cyto-
toxicity, owing to HBO-improved energy metabolism.
A significant amount of work was done in order to describe 
protective effects of HBO preconditioning in different 
models of brain injury, and it was accepted that initial oxi-
dative stress acts as a trigger that up-regulates the antioxi-
dant enzymes including SOD2 (64). We have also recently 
reported that HBOT can improve locomotor performances 
in rats after cortical ablation (19).
In conclusion, the results of this study imply that applica-
tion of HBOT, via altering SOD2 expression, may attenuate 
imbalance between oxidants and antioxidants that occurs 
after brain injury, and in that way contributes to the mainte-
nance of pro-/antioxidant homeostasis. Moreover, a reduced 
number of dying neurons in the injured cortex suggested 
that HBOT could contribute to reducing secondary injury 
after TBI. Although precise mechanisms remain elusive, we 
believe that presented results may be of importance when 
considering HBO as an adjunctive therapy for patients with 
brain injury. Further studies should be performed to eluci-
date whether observed changes in SOD2 expression at pro-
tein and mRNA level are accompanied with corresponding 
changes in SOD2 activity and ROS status.
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